Literature DB >> 12747657

Transient third nerve palsy in a young patient with intracranial arteriovenous malformation.

G Wu1, A Agrawal, F D Ghanchi.   

Abstract

PURPOSE: To describe a patient with transient third nerve palsy as the possible presenting sign of intracranial arteriovenous malformation.
METHOD: Case report. RESULT: A 24-year-old female presented to ophthalmic casualty with sudden onset binocular diplopia and was diagnosed to have right sided partial third nerve palsy. Within 30 hours the third nerve palsy had recovered completely. A MRI scan and subsequent carotid angiogram revealed a large, high flow, trans-cortical Spetzler-Martin grade 4 arteriovenous malformation. The feeder vessel of the AVM originated from the right middle cerebral artery. Superficial venous drainage was via the superficial middle cerebral vein to the right transverse sinus. The deep venous drainage was via thalamostriate veins into markedly dilated internal cerebral vein and vein of Galen (Great cerebral vein). Venous reflux was noted around the midbrain from the vein of Galen.
CONCLUSIONS: Transient third nerve palsy may rarely occur secondary to intracranial arteriovenous malformation. Ophthalmologists should consider neuroimaging in the investigations for transient cases of III nerve palsy in young patients.

Entities:  

Mesh:

Year:  2003        PMID: 12747657     DOI: 10.1177/112067210301300315

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Cerebral arteriovenous malformation presenting as isolated bilateral pupil-sparing oculomotor, pseudoabducens palsy, and hemiataxia.

Authors:  I-Hsu Chen; Yi-Hui Lin; Meng-Ni Wu; Chiou-Lian Lai; Li-Min Liou
Journal:  Neurol Sci       Date:  2018-02-17       Impact factor: 3.307

2.  Arteriovenous malformation of the vestibulocochlear nerve.

Authors:  Adam Tucker; Masao Tsuji; Yoshitaka Yamada; Kenichiro Hanabusa; Tohru Ukita; Hiroji Miyake; Takehisa Ohmura
Journal:  World J Clin Cases       Date:  2015-07-16       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.